Abstract
Normal and pathologic neurobiological processes influence brain morphology in coordinated ways that give rise to patterns of structural covariance (PSC) across brain regions and individuals during brain aging and brain diseases. The genetic underpinnings of these patterns remain largely unknown. We apply a stochastic multivariate factorization method to a diverse population of 50,699 individuals (12 studies, 130 sites) and derive data-driven, multi-scale PSCs of regional brain size. PSCs were significantly correlated with 915 genomic loci in the discovery set, 617 of which are novel, and 72% were independently replicated. Key pathways influencing PSCs involved reelin signaling, apoptosis, neurogenesis, and appendage development, while pathways of breast cancer indicate potential interplays between brain metastasis and PSCs associated with neurodegeneration and dementia. Using machine learning, multi-scale PSCs effectively derive imaging signatures of several brain diseases. Our results elucidate new genetic and biological underpinnings that influence structural covariance patterns in the human brain.
Competing Interest Statement
Competing interest are detailed in the manuscript
Funding Statement
The iSTAGING consortium is a multi-institutional effort funded by NIA by RF1 AG054409.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All studies were approved by the corresponding Institutional Review Boards. Each participant consented to be part of the imaging, cognition, and/or genetic biobanks. Data from the UKBB for this project pertains to application 35148. Biomarkers for Older Controls at Risk for Dementia (BIOCARD): The BIOCARD study was approved by the JHU Institutional Review Board. The Johns Hopkins School of Medicine IRB, No. NA_00027232. All participants provided written, informed consent in accordance with the Declaration of Helsinki. Psychosis Heterogeneity Evaluated via Dimensional Neuroimaging: PHENOM - the original ethics statements for each of the three sites that provided data included in PHENOM: "Site 1 (USA): This study was approved by the Institutional Review Board of the University of Pennsylvania. Written informed consent was obtained from each participant. Site 2 (Germany): The study protocols were approved by the ethics committee of Ludwig-Maximilians University. Subjects provided their written informed consent prior to MRI and clinical examination. Site 3 (China): The study was approved by the Ethics Committee of Tianjin Medical University General Hospital, Tianjin, China. Written informed consent was obtained from each subject before study enrollment." Wisconsin Registry for Alzheimers Prevention (WRAP): WRAP: "WRAP protocol and procedures are reviewed and approved by the Health Sciences Institutional Review Board of the University of Wisconsin and the other medical centers involved in this research."
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The GWAS summary statistics corresponding to this study are publicly available on the BRIDGEPORT web portal (https://www.cbica.upenn.edu/bridgeport/). The GWAS summary statistics used in the genetic correlation analyses were fetched from the GWAS Catalog platform (https://www.ebi.ac.uk/gwas), although each study provided the original links; The GWAS Catalog platform was used to query if the SNPs identified by MuSIC were previously reported.
